Literature DB >> 30280598

Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.

Zhengwei Ma1, Qingqing Wei1, Ming Zhang1, Jian-Kang Chen1, Zheng Dong1.   

Abstract

Renal fibrosis is a common pathological feature in chronic kidney disease (CKD), including diabetic kidney disease (DKD) and obstructive nephropathy. Multiple microRNAs have been implicated in the pathogenesis of both DKD and obstructive nephropathy, although the overall role of microRNAs in tubular injury and renal fibrosis in CKD is unclear. Dicer (a key RNase III enzyme for microRNA biogenesis) was specifically ablated from kidney proximal tubules in mice via the Cre-lox system to deplete micoRNAs. Proximal tubular Dicer knockout (PT- Dicer KO) mice and wild-type (WT) littermates were subjected to streptozotocin (STZ) treatment to induce DKD or unilateral ureteral obstruction (UUO) to induce obstructive nephropathy. Renal hypertrophy, renal tubular apoptosis, kidney inflammation, and tubulointerstitial fibrosis were examined. Compared with WT mice, PT- Dicer KO mice showed more severe tubular injury and renal inflammation following STZ treatment. These mice also developed higher levels of tubolointerstitial fibrosis. Meanwhile, PT- Dicer KO mice had a significantly higher Smad2/3 expression in kidneys than WT mice (at 6 mo of age) in both control and STZ-treated mice. Similarly, UUO induced more severe renal injury, inflammation, and interstitial fibrosis in PT- Dicer KO mice than WT. Although we did not detect obvious Smad2/3 expression in sham-operated mice (2-3 mo old), significantly more Smad2/3 was induced in obstructed PT- Dicer KO kidneys. These results supported a protective role of Dicer-dependent microRNA synthesis in renal injury and fibrosis development in CKD, specifically in DKD and obstructive nephropathy. Depletion of Dicer and microRNAs may upregulate Smad2/3-related signaling pathway to enhance the progression of CKD.

Entities:  

Keywords:  Dicer; Smad2/3; diabetic kidney disease; fibrosis; microRNA; unilateral urethral obstruction

Mesh:

Substances:

Year:  2018        PMID: 30280598      PMCID: PMC6337000          DOI: 10.1152/ajprenal.00402.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  69 in total

1.  miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.

Authors:  Arthur C K Chung; Xiao R Huang; Xiaoming Meng; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

2.  The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis.

Authors:  A Bohle; M Wehrmann; O Bogenschütz; C Batz; C A Müller; G A Müller
Journal:  Pathol Res Pract       Date:  1991-03       Impact factor: 3.250

3.  Clinical and histological correlation of diabetic nephropathy.

Authors:  Tameem Afroz; Radha Sagar; Sandeep Reddy; Sridhar Gandhe; K G Rajaram
Journal:  Saudi J Kidney Dis Transpl       Date:  2017 Jul-Aug

4.  Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.

Authors:  S W Hong; M Isono; S Chen; M C Iglesias-De La Cruz; D C Han; F N Ziyadeh
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.

Authors:  Scott J Harvey; George Jarad; Jeanette Cunningham; Seth Goldberg; Bernhard Schermer; Brian D Harfe; Michael T McManus; Thomas Benzing; Jeffrey H Miner
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

6.  Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells.

Authors:  Yi Yang; Lei Liu; Junchao Cai; Jueheng Wu; Hongyu Guan; Xun Zhu; Jie Yuan; Shengping Chen; Mengfeng Li
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

Review 7.  Tubulointerstitial injury and the progression of chronic kidney disease.

Authors:  Kavita S Hodgkins; H William Schnaper
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

8.  Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids.

Authors:  Ye Zhang; Bingyu Guo; Qiang Hui; Wei Li; Peng Chang; Kai Tao
Journal:  Mol Med Rep       Date:  2018-05-29       Impact factor: 2.952

Review 9.  MicroRNAs in Diabetic Kidney Disease.

Authors:  Rong Li; Arthur C K Chung; Xueqing Yu; Hui Y Lan
Journal:  Int J Endocrinol       Date:  2014-01-14       Impact factor: 3.257

10.  Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study.

Authors:  Bancha Satirapoj; Kasemsan Aramsaowapak; Theerasak Tangwonglert; Ouppatham Supasyndh
Journal:  J Diabetes Res       Date:  2016-09-08       Impact factor: 4.011

View more
  6 in total

1.  miR-214 represses mitofusin-2 to promote renal tubular apoptosis in ischemic acute kidney injury.

Authors:  Yu Yan; Zhengwei Ma; Jiefu Zhu; Mengru Zeng; Hong Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-31

2.  Formononetin Attenuates Renal Tubular Injury and Mitochondrial Damage in Diabetic Nephropathy Partly via Regulating Sirt1/PGC-1α Pathway.

Authors:  Qunwei Huang; Hongbo Chen; Kai Yin; Yilan Shen; Kanghong Lin; Xieyi Guo; Xiang Zhang; Niansong Wang; Wenfeng Xin; Youhua Xu; Dingkun Gui
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

3.  FOXO1-Mediated Downregulation of RAB27B Leads to Decreased Exosome Secretion in Diabetic Kidneys.

Authors:  Mengru Zeng; Jin Wen; Zhengwei Ma; Li Xiao; Yutao Liu; Sangho Kwon; Yu Liu; Zheng Dong
Journal:  Diabetes       Date:  2021-02-17       Impact factor: 9.337

4.  Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.

Authors:  Meiling Zheng; Juan Cai; Zhiwen Liu; Shaoqun Shu; Ying Wang; Chengyuan Tang; Zheng Dong
Journal:  J Cell Mol Med       Date:  2019-04-16       Impact factor: 5.310

5.  DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice.

Authors:  Xiaozhou Li; Jian Pan; Huiling Li; Guangdi Li; Xiangfeng Liu; Bohao Liu; Zhibiao He; Zhengyu Peng; Hongliang Zhang; Yijian Li; Xudong Xiang; Xiangping Chai; Yunchang Yuan; Peilin Zheng; Feng Liu; Dongshan Zhang
Journal:  Nat Commun       Date:  2020-09-18       Impact factor: 14.919

6.  Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway.

Authors:  Man Xu; Shumin Li; Jiajia Wang; Songming Huang; Aihua Zhang; Yue Zhang; Wei Gu; Xiaowen Yu; Zhanjun Jia
Journal:  Front Med (Lausanne)       Date:  2021-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.